OpGen, Inc. Files 8-K: Material Agreement and Other Events
Ticker: CFOR · Form: 8-K · Filed: Apr 29, 2024 · CIK: 1293818
| Field | Detail |
|---|---|
| Company | Opgen Inc (CFOR) |
| Form Type | 8-K |
| Filed Date | Apr 29, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $218,000, $176,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, financials
TL;DR
OpGen filed an 8-K on 4/23 for a material agreement & other events. Check financials.
AI Summary
On April 23, 2024, OpGen, Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company also reported other events and filed financial statements and exhibits. OpGen, Inc. is incorporated in Delaware and its principal executive offices are located in Rockville, MD.
Why It Matters
This 8-K filing indicates significant corporate activity for OpGen, Inc., including the execution of a material agreement and the submission of financial information, which could impact investors' understanding of the company's current status and future direction.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could represent significant business changes, but the lack of specific details necessitates caution.
Key Players & Entities
- OpGen, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Rockville, MD (location) — Principal executive offices
- April 23, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the Material Definitive Agreement entered into by OpGen, Inc. on April 23, 2024?
The filing states that OpGen, Inc. entered into a Material Definitive Agreement on April 23, 2024, but the specific details of this agreement are not provided in this document.
What other items are reported in this 8-K filing besides the material agreement?
In addition to the entry into a Material Definitive Agreement, the filing also reports 'Other Events' and 'Financial Statements and Exhibits'.
When was OpGen, Inc. incorporated, and where are its principal executive offices located?
OpGen, Inc. is incorporated in Delaware and its principal executive offices are located at 9717 Key West Ave, Suite 100, Rockville, MD 20850.
What is the Commission File Number for OpGen, Inc.?
The Commission File Number for OpGen, Inc. is 001-37367.
What is the SIC code for OpGen, Inc.?
The Standard Industrial Classification (SIC) code for OpGen, Inc. is 8071, which corresponds to SERVICES-MEDICAL LABORATORIES.
Filing Stats: 806 words · 3 min read · ~3 pages · Grade level 12.7 · Accepted 2024-04-29 16:28:25
Key Financial Figures
- $218,000 — e purchase price for the transaction is $218,000, and the transaction is expected to clo
- $176,000 — tory and assets for up to an additional $176,000. Until such sale for the remaining inve
Filing Documents
- opgeninc_8k.htm (8-K) — 33KB
- opgeninc_ex10-1.htm (EX-10.1) — 25KB
- opgeninc_ex99-1.htm (EX-99.1) — 8KB
- ex10-1_001.jpg (GRAPHIC) — 31KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001829126-24-002907.txt ( ) — 292KB
- opgn-20240423.xsd (EX-101.SCH) — 3KB
- opgn-20240423_lab.xml (EX-101.LAB) — 33KB
- opgn-20240423_pre.xml (EX-101.PRE) — 22KB
- opgeninc_8k_htm.xml (XML) — 4KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On April 23, 2024, OpGen, Inc. (the "Company") entered into a letter agreement (the "Agreement") with Camtech Pte Ltd, a Singaporean family office ("Camtech"), for the sale of certain of the Company's inventory and customer contracts for its Unyvero products. The transaction was entered into following the prior acquisition by Camtech in April 2024 of the assets from the Company's subsidiary, Curetis GmbH ("Curetis"), as part of Curetis' insolvency proceedings. The purchase price for the transaction is $218,000, and the transaction is expected to close in May 2024. As part of such Agreement, the Company also offered Camtech the opportunity to purchase its remaining Unyvero inventory and assets for up to an additional $176,000. Until such sale for the remaining inventory is completed, OpGen will maintain commercial operations and service support for the Unyvero systems. The foregoing transactions are part of the Company's planned exit from its Unyvero business, as the Company continues to seek strategic alternatives. The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that are intended to qualify for the safe harbor from liability established thereunder. Such forward-looking statements are subject to risks and uncertainties that are often difficult to predict, are beyond the Company's control, and which may cause results to differ materially from expectations, including the risks that the transactions described herein will not be consummated. In addition, for a further discussion of factors that could materially affect the outcome of the Company's forward-looking statements and its future results and financial condition, see "Risk Factors" in Part I, Item 1A, of the Company's Annual Report on Form 10-K for the year ended December 31, 2022 and its other reports filed with the Securities and Exchange Commission. The Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
01 Other Events
Item 8.01 Other Events. On April 29, 2024, the Company issued a press release announcing the transactions contemplated by the Agreement. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 10.1 Letter Agreement, dated April 23, 2024, between OpGen, Inc. and Camtech Pte Ltd 99.1 Press release dated April 29, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: April 29, 2024 OpGen, Inc. By: /s/ David Lazar Name: David Lazar Title: Chairman and Chief Executive Officer 2